Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kan He

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Journal of Natural Products|April 29, 2006
Sesquiterpene lactones from Inula britannica and their cytotoxic and apoptotic effects on human cancer cell linesNaisheng Bai, Ching-Shu Lai, Kan He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2008
Apixaban metabolism and pharmacokinetics after oral administration to humansNirmala Raghavan, Charles E Frost, Zhigang Yu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 31, 2004
The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and applicationHarvey Wong, Scott J Grossman, Stephen A Bai, et al.
Biomaterials|November 13, 2017
Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinomaZheng Wang, Zhimin Chang, Mengmeng Lu, et al.
RSC Advances|May 11, 2022
Berberine-based carbon dots for selective and safe cancer theranosticsFan Zhang, Ming Zhang, Xiao Zheng, et al.
European Journal of Pharmacology|January 22, 2021
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1Yawei Zhao, Xuehan Yang, Jingtong Zhao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 6, 2013
Characterization of efflux transporters involved in distribution and disposition of apixabanDonglu Zhang, Kan He, John J Herbst, et al.
Theranostics|August 8, 2018
Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranosticsXiao Zheng, Fan Zhang, Yawei Zhao, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humansTheunis C Goosen, Doré Cillié, David G Bailey, et al.
Oncology Reports|October 14, 2014
Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanismsYan Li, Jiying Wang, Xiaoyan Li, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Journal of Natural Products|April 29, 2006
Sesquiterpene lactones from Inula britannica and their cytotoxic and apoptotic effects on human cancer cell linesNaisheng Bai, Ching-Shu Lai, Kan He, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2008
Apixaban metabolism and pharmacokinetics after oral administration to humansNirmala Raghavan, Charles E Frost, Zhigang Yu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 31, 2004
The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and applicationHarvey Wong, Scott J Grossman, Stephen A Bai, et al.
Biomaterials|November 13, 2017
Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinomaZheng Wang, Zhimin Chang, Mengmeng Lu, et al.
RSC Advances|May 11, 2022
Berberine-based carbon dots for selective and safe cancer theranosticsFan Zhang, Ming Zhang, Xiao Zheng, et al.
European Journal of Pharmacology|January 22, 2021
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1Yawei Zhao, Xuehan Yang, Jingtong Zhao, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 6, 2013
Characterization of efflux transporters involved in distribution and disposition of apixabanDonglu Zhang, Kan He, John J Herbst, et al.
Theranostics|August 8, 2018
Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranosticsXiao Zheng, Fan Zhang, Yawei Zhao, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humansTheunis C Goosen, Doré Cillié, David G Bailey, et al.
Oncology Reports|October 14, 2014
Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanismsYan Li, Jiying Wang, Xiaoyan Li, et al.
Pageof 19